Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,628
datasets available to search
ShareScore release 0.9.0
Dataset results
1,628 results for “type safety”
Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects
ClinicalTrials.gov study NCT04129528. IPD Sharing: YES. Countries: 6. Publications: 0.
Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
ClinicalTrials.gov study NCT00044668. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Effectiveness and Safety of Salba on Weight Loss in Overweight Individuals With Type 2 Diabetes
ClinicalTrials.gov study NCT01403571. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Long-Term Safety and Efficacy on Gene Therapy in Glycogen Storage Disease Type Ia
ClinicalTrials.gov study NCT03970278. IPD Sharing: NO. Countries: 4. Publications: 0.
A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients
ClinicalTrials.gov study NCT00690287. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00099931. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01427699. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who
ClinicalTrials.gov study NCT01356849. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes
ClinicalTrials.gov study NCT00095082. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes
ClinicalTrials.gov study NCT01918865. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes
ClinicalTrials.gov study NCT00435981. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children
ClinicalTrials.gov study NCT01021397. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01169818. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone
ClinicalTrials.gov study NCT00604253. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin
ClinicalTrials.gov study NCT02452632. IPD Sharing: YES. Countries: 1. Publications: 1.
A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia
ClinicalTrials.gov study NCT00300287. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00355849. IPD Sharing: YES. Countries: 12. Publications: 1.
Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy
ClinicalTrials.gov study NCT03332771. IPD Sharing: YES. Countries: 4. Publications: 0.
A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients
ClinicalTrials.gov study NCT01057628. IPD Sharing: NO. Countries: 1. Publications: 1.
Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
ClinicalTrials.gov study NCT02291874. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.